Morning Overview on MSN
Study maps prostate immune niches, finds T cells linger for months
Prostate cancer has long frustrated immunologists. Checkpoint inhibitors that unleash the immune system against tumors in the ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell weaponry we might use to save lives. Researchers have discovered that the immune ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Two University of Kentucky Markey Cancer Center researchers have each received a Research Scholar Grant from the American ...
Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.
Hosted on MSN
Scientists uncover immune cells that help prostate cancer resist treatment—and reveal a way to stop them
Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back. Subscribe to our newsletter for the latest sci-tech ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...
Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow - and how blocking them could help the body fight back. The study, published July 2 as the cover story in ...
Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But what does it mean for this type of cancer to be called aggressive? As a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results